Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Facing My Mortality from Cancer Made Me Grateful for Loved Ones

March 28th 2023, 9:00pm

Article

Twenty-five years ago, I was diagnosed with ovarian cancer, which sparked fears of leaving my loved ones behind.

Palliative Care Decreases Hospital Readmissions in Ovarian Cancer

March 27th 2023, 9:00pm

Video

Patients with ovarian cancer who utilized palliative care tended to have fewer hospital readmissions than those who did not, according to a recent study.

Strange Tattoos: A Look at My Cancer Experience

March 27th 2023, 3:00pm

Article

The temporary tattoos that guided the radiation for my cancer treatment were not beautiful, artistic or cool — they were more than that.

An Innovative Approach to Chemotherapy

March 13th 2023, 7:00pm

Article

Positive results have emerged from a trial testing PIPAC, a procedure used for appendiceal, ovarian, gastric and colon cancers that works by spraying chemotherapy directly onto tumors.

Novel Drug to Be Studied in Ovarian Cancer

February 10th 2023, 2:00pm

Article

After promising phase 1 results, ART0380 will be studied in a randomized phase 2 trial for patients with platinum-resistant ovarian cancer.

Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer

February 1st 2023, 6:00pm

Article

I’m coming up on my 10-year cancer anniversary, and it feels bittersweet.

Ongoing Trial Shows Positive Response Rates With MEK Inhibitor Combo in Ovarian Cancer Subset

January 30th 2023, 2:10pm

Article

Women with low-grade serous ovarian cancer treated with avutometinib and defactinib experienced positive response rates compared with avutometinib alone.

First Patient Dosed with AVB-001 in Trial for Relapsed Refractory Ovarian Cancer

January 19th 2023, 2:00pm

Article

The trial is evaluating the safety and efficacy of AVB-001 patients with relapsed refractory ovarian cancer.

Beta-Blockers May Improve Post-Surgical Survival in Women With Ovarian Cancer, Heart Conditions

January 18th 2023, 8:00pm

Article

Women who were taking beta-blockers, a medicine to treat heart conditions like high blood pressure, among others, near the time of surgery for epithelial ovarian cancer may confer a survival benefit years after undergoing a procedure.

FDA Approval of Elahere Represents a ‘Step Forward’ for Platinum-Resistant Ovarian Cancer Subset

November 22nd 2022, 10:00pm

Article

One expert said that the FDA approval of the antibody-drug conjugate Elahere represents a new treatment option for patients with folate receptor alpha-positive, platinum resistant ovarian cancer.